Concomitantly, significantly lower levels of MIG (CXCL9), an IFN-γ-induced ligand for CXCR3, were also observed in SU compared with DS participants’ plasma at week 117 (Fig. 4c). The gene discussed is IFNG; the disease is Dravet syndrome.